Patent · US Active

CCK-1 receptor modulators

US7456208B2 · kind B2 · utility

0Cited by
7References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 3, 2007
Grant dateNov 25, 2008
Priority date—
Expiry dateJul 3, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.